Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bischofberger

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|July 27, 2001
Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infectionK K Van Rompay, M B McChesney, N L Aguirre, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humansT Igarashi, C R Brown, Y Endo, et al.
European Journal of Pharmacology|December 5, 1996
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbilsD K Von Lubitz, R C Lin, I A Paul, et al.
European Journal of Pharmacology|April 29, 1996
Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonistD K Von Lubitz, M Beenhakker, R C Lin, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in miceL Naesens, N Bischofberger, P Augustijns, et al.
The Journal of Infectious Diseases|February 1, 1994
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaquesC C Tsai, K E Follis, A Sabo, et al.
Science (New York, N.Y.)|November 17, 1995
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenineC C Tsai, K E Follis, A Sabo, et al.
AIDS Research and Human Retroviruses|May 29, 2000
Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaquesP Silvera, P Racz, K Racz, et al.
AIDS (London, England)|July 14, 1998
Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infectionK K Van Rompay, C J Berardi, N L Aguirre, et al.
Journal of Virology|April 29, 1998
Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatmentC C Tsai, P Emau, K E Follis, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|July 27, 2001
Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infectionK K Van Rompay, M B McChesney, N L Aguirre, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humansT Igarashi, C R Brown, Y Endo, et al.
European Journal of Pharmacology|December 5, 1996
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbilsD K Von Lubitz, R C Lin, I A Paul, et al.
European Journal of Pharmacology|April 29, 1996
Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonistD K Von Lubitz, M Beenhakker, R C Lin, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in miceL Naesens, N Bischofberger, P Augustijns, et al.
The Journal of Infectious Diseases|February 1, 1994
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaquesC C Tsai, K E Follis, A Sabo, et al.
Science (New York, N.Y.)|November 17, 1995
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenineC C Tsai, K E Follis, A Sabo, et al.
AIDS Research and Human Retroviruses|May 29, 2000
Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaquesP Silvera, P Racz, K Racz, et al.
AIDS (London, England)|July 14, 1998
Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infectionK K Van Rompay, C J Berardi, N L Aguirre, et al.
Journal of Virology|April 29, 1998
Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatmentC C Tsai, P Emau, K E Follis, et al.
Pageof 6